Assenagon Asset Management S.A. trimmed its stake in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) by 54.6% during the first quarter, HoldingsChannel.com reports. The fund owned 85,246 shares of the biopharmaceutical company’s stock after selling 102,710 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Corbus Pharmaceuticals were worth $800,000 at the end [...]
2026-07-03 07:15:55